Scholar Rock Holding (SRRK) Leases (2018 - 2026)
Scholar Rock Holding's quarterly Leases came in at $10.1 million in Q1 2026, down 29.6% year-on-year from $14.4 million in Q1 2025, and down 2.34% quarter-over-quarter from $10.4 million in Q4 2025.
Scholar Rock Holding has reported Leases for 9 years, with the latest figure at $10.1 million in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 29.6% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 29.6% YoY), and the FY2025 full-year result was $10.4 million, down 33.64% from the prior year.
- Leases for Q1 2026 stood at $10.1 million, down from $10.4 million in the prior quarter.
- The five-year high for Leases was $23.8 million in Q1 2022, with the low at $9.8 million in Q1 2024.
- Average Leases over 5 years is $15.3 million, with a median of $14.9 million recorded in 2023.
- Year-over-year, Leases slumped 41.4% in 2024 and surged 46.89% in 2025.
- Tracing SRRK's Leases over 5 years: stood at $18.5 million in 2022, then plunged by 38.43% to $11.4 million in 2023, then jumped by 37.02% to $15.6 million in 2024, then plunged by 33.64% to $10.4 million in 2025, then dropped by 2.34% to $10.1 million in 2026.
- The last three Leases figures came in at $10.1 million (Q1 2026), $10.4 million (Q4 2025), and $11.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.14 Mn |
| Dec 31, 2025 | 10.38 Mn |
| Sep 30, 2025 | 11.77 Mn |
| Jun 30, 2025 | 13.11 Mn |
| Mar 31, 2025 | 14.40 Mn |
| Dec 31, 2024 | 15.64 Mn |
| Sep 30, 2024 | 16.83 Mn |
| Jun 30, 2024 | 17.98 Mn |
| Mar 31, 2024 | 9.81 Mn |
| Dec 31, 2023 | 11.42 Mn |
| Sep 30, 2023 | 13.00 Mn |
| Jun 30, 2023 | 14.89 Mn |
| Mar 31, 2023 | 16.73 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Sep 30, 2022 | 20.32 Mn |
| Jun 30, 2022 | 22.06 Mn |
| Mar 31, 2022 | 23.77 Mn |
| Dec 31, 2021 | 25.44 Mn |
| Sep 30, 2021 | 27.08 Mn |
| Jun 30, 2021 | 28.73 Mn |
| Mar 31, 2021 | 29.68 Mn |
| Dec 31, 2020 | 32.26 Mn |
| Sep 30, 2020 | 34.94 Mn |
| Jun 30, 2020 | 3.92 Mn |
| Mar 31, 2020 | 4.19 Mn |
| Dec 31, 2019 | 4.45 Mn |
| Sep 30, 2019 | 4.70 Mn |
| Jun 30, 2019 | 4.86 Mn |
| Mar 31, 2019 | 5.11 Mn |
| Dec 31, 2018 | 44,000.00 |
| Sep 30, 2018 | 44,000.00 |